saeed A. musa

Nigerian Physician 🇳🇬 | MPH Candidate | Aspiring Cancer Researcher | Precision Oncology • Genomics • Clinical Research • Global Health | Lifelong learner

[National Cancer Institute @theNCI]

On #GISTAwarenessDay, there's encouraging news for people with advanced GIST. Recent clinical trial results show that continuing imatinib (Gleevec) can help people live longer and delay treatment resistance. Evidence like this helps guide better care. https://t.co/tHUv9qm7e5

[NICRAT @NicratGov]

📢 𝗖𝗔𝗟𝗟 𝗙𝗢𝗥 𝗔𝗕𝗦𝗧𝗥𝗔𝗖𝗧𝗦 – 𝗜𝗡𝗧𝗘𝗥𝗡𝗔𝗧𝗜𝗢𝗡𝗔𝗟 𝗖𝗔𝗡𝗖𝗘𝗥 𝗪𝗘𝗘𝗞 (𝗜𝗖𝗪) 𝟮𝟬𝟮𝟲

The National Institute for Cancer Research and Treatment (NICRAT), in collaboration with the Federal Ministry of Health Nigeria, is pleased to invite researchers, clinicians, public health professionals, policymakers, innovators, students, development partners, and cancer advocates to submit abstracts for presentation at the
𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗮𝗻𝗰𝗲𝗿 𝗪𝗲𝗲𝗸 (𝗜𝗖𝗪) 𝟮𝟬𝟮𝟲 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲.

📅 Date: 5th – 9th October 2026
📍 Venue: Abuja, Nigeria

Theme:
𝗨𝗻𝗶𝘁𝗲𝗱 𝗔𝗴𝗮𝗶𝗻𝘀𝘁 𝗖𝗮𝗻𝗰𝗲𝗿: 𝗕𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗥𝗲𝘀𝗶𝗹𝗶𝗲𝗻𝘁, 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲, 𝗮𝗻𝗱 𝗘𝗾𝘂𝗶𝘁𝗮𝗯𝗹𝗲 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗔𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗖𝗮𝗻𝗰𝗲𝗿 𝗖𝗮𝗿𝗲 𝗖𝗼𝗻𝘁𝗶𝗻𝘂𝘂𝗺

ICW 2026 will bring together national and international experts, researchers, healthcare professionals, policymakers, survivors, civil society organizations, and industry leaders to share cutting-edge research, innovative practices, and practical solutions aimed at strengthening cancer prevention, early detection, diagnosis, treatment, palliative care, research, and policy across Africa.

Abstract Submission Period: 🗓️ 9th July – 7th August 2026

Conference Sub-Themes
🔹 Policy, Leadership, Commitment, and Governance for Equitable Cancer Control
🔹 Research, Innovation, and Data for Evidence-Driven Cancer Solutions
🔹 Quality Cancer Care, Implementation, and Patient-Centred Practice

Selected abstracts will be considered for Oral and Poster Presentations, providing an excellent platform to showcase impactful research and foster collaborations that advance cancer control.

Register & Submit
📝 Conference Registration: https://t.co/XOzXgFeMKP
📄 Abstract Submission: https://t.co/n7RWFkVhCs
🎤 Speaker Registration: https://t.co/zaurn3YsMZ

Be part of the movement to shape the future of cancer care in Nigeria and beyond. Share your ideas. Drive change. Together, we can conquer cancer.

#ICW2026 #InternationalCancerWeek #CallForAbstracts #CancerResearch #CancerCare #Oncology #PublicHealth #Innovation #CancerPrevention #CancerControl #NICRAT #FMOH #Abuja2026 #TogetherWeCanConquerCancer

[Muharram 1448 عمر @adsadiq_danladi]

Great sense of accountability. I had a dissimilar experience with my Alma mater- ABU Zaria who released me on study leave without pay when I got a 2 year contract elsewhere.

In less than a year, I got a letter asking me to return to my post or risk losing it. I refused and got fired.

Thankfully, I didn’t owe them a dime so nothing to refund.

Unfortunately I forfeited my pension contributions for 3 years.

Alhamdulillah for life’s experience

[A_Z GADGETS @ayzade_abdool]

Best awuf deal 🥰 Hp elitebook 1030 g3/4 8th gen X360 Core i7 Touch screen 256 ssd 16gb ram Keyboard light 13.3inch Laptop and charger 🔌 Price: 420k with 512 ssd 450k

[NICRAT @NicratGov]

𝗡𝗜𝗖𝗥𝗔𝗧 𝗖𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗱 𝘁𝗼 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿 𝗖𝗮𝗿𝗲, 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻 - 𝗣𝗿𝗼𝗳. 𝗠𝗮𝗹𝗮𝗺𝗶

The Director General of the National Institute for Cancer Research and Treatment (NICRAT), Prof. Usman Malami Aliyu, has reiterated the commitment of his Institute to advancing cancer prevention, research, early detection, treatment and access through evidence -based policies, strategic partnerships and innovative programme that are transforming cancer care in Nigeria.

He stated this while making a presentation titled: Reducing Africa's cancer burden: Insight from the Nigeria Model, at the ongoing Best of ASCO Africa 2026 Conference, in Abuja.

He disclosed that the institute has trained about 140 early career scientists under its Strengthening Institutional Capacity in Cancer Research (SINCA) programme and awarded research grants to 24 researchers to strengthen local capacity.

He said the institute has also completed the first phase of Nigeria’s Cancer Genome Study, which, according to him, seeks to identify genetic mutations associated with common cancers among Nigerians and lay the foundation for precision medicine tailored to patients in the country.

Prof. Malami, therefore, charged participants to use the conference as a platform to exchange knowledge, foster partnerships and develop practical solutions that will accelerate progress towards equitable Cancer care across the African continent.

The conference is with the theme: 'From Global Discovery to Local Discovery: Driving Africa to the cutting edge of cancer care.

#NICRAT #ASCO #SINCA #CancerCare

[Medscape @Medscape]

The physician-patient relationship is built on trust. What happens to that trust when AI is involved? Here, Robert Wachter, MD, shares his views. https://t.co/Ff619ck2yl

[Dr. Yakubu Sani Wudil @yakubwudil]

The full video for the AYMP webinar on Career Development Strategy and Preparing for Global Opportunities has been uploaded to YouTube.

You can watch via the link: https://t.co/erlbStnkOV

Best wishes!

[National Cancer Institute @theNCI]

Better data drives better science.

With data from more than 747,000 participants, @AllofUsResearch is now the world's largest integrated genomic and electronic health record database—giving researchers powerful new opportunities to advance precision medicine and improve health for all.

https://t.co/rDn7ZdXvbn

[World Health Organization (WHO) @WHO]

Do you know the most common types of cancer in children?

These are:
- leukemias,
- brain tumours,
- lymphomas, and
- solid tumours such as neuroblastoma and Wilms tumour.

While childhood cancer is rare, it can happen.
When cancer is found early and treatment begins without delay, a child has a far better chance of surviving and growing up healthy.

[WHO/Europe @WHO_Europe]

#Alcohol can unravel the brain's connections.

Alcohol damages the #brain, leading to nerve cell death and the loss of neural connections.

When this process progresses more rapidly, it is often associated with neurological disorders, especially #dementia.

#BrainHealth

[HouseOfKhairat🛍🎁 @Houseofkhairat_]

N100,000

40-46

Location: Lagos (delivery nationwide)

[Medscape @Medscape]

💻 Virtual Event!
🥼 Neurologists, Neuroradiologists, PCPs, Geriatricians, Psychiatrists, NPs, PAs, and Nurses.
🧠 Learners will be better able to summarize recent data on the use of AATs for early stages of AD and select and monitor patients receiving an AAT for the management of early stages of AD.

👉 https://t.co/kXI1Nuu6qo

[saeed A. musa @imraansaed63]

@yakubwudil Very educative, looking forward to re connect again

[Dr. Yakubu Sani Wudil @yakubwudil]

How did you find the webinar today?

[National Cancer Institute @theNCI]

Although dark skin does not burn in the sun as easily as fair skin, everyone is at risk for skin cancer. It doesn't matter whether you consider your skin light, dark, or somewhere in between. Learn about how you can protect your skin from cancer. https://t.co/MhTIk0g4hd

[NICRAT @NicratGov]

🇳🇬 ᴀ ʟᴀɴᴅᴍᴀʀᴋ ᴍᴏᴍᴇɴᴛ ꜰᴏʀ ᴄᴀɴᴄᴇʀ ᴄᴏɴᴛʀᴏʟ ɪɴ ɴɪɢᴇʀɪᴀ!

The National Institute for Cancer Research and Treatment (NICRAT), in collaboration with the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC), is set to launch Nigeria's first-ever Cancer Burden Report (2024) on the 18th of August, 2026, here in Abuja.

This groundbreaking report provides a comprehensive national assessment of the cancer burden in Nigeria and highlights progress in strengthening cancer surveillance across the country.

Join us as we bring together key stakeholders to shape the future of cancer surveillance, prevention, early detection and treatment in Nigeria.

🗓️ Save the date: 18 August 2026 📍 Abuja

[saeed A. musa @imraansaed63]

@UCSDCancer Impressive story

[UC San Diego Health Moores Cancer Center @UCSDCancer]

When Austin Smith ran out of options close to home, he traveled from Phoenix to UC San Diego Health, and found a path forward he didn't know existed.

Diagnosed with stage IV gastrointestinal stromal tumor (GIST), a rare and aggressive cancer, Austin connected with Jason Sicklick, MD, FACS and Adam Burgoyne, MD, PhD at UC San Diego Moores Cancer Center. They enrolled him in a clinical trial involving temozolomide (TMZ).

The results were remarkable: significant tumor shrinkage that made a complex surgery possible. This July, Sarcoma and Bone Cancer Awareness Month, we're sharing Austin's story as a reminder of what's at stake, and what becomes possible when patients have access to the right team and the right trial at the right time.

Read more about Austin's story and Clinical Trials Day: https://t.co/IFnlcezR0S
#SarcomaAwarenessMonth #GIST #ClinicalTrials #CancerCare #MooresCancerCenter #RareCancer

[Mayo Clinic @MayoClinic]

Early detection is one of the most effective ways to improve outcomes for colorectal cancer.

Changes in bowel habits can be an important warning sign and should be discussed with your healthcare team, even if the conversation feels uncomfortable.

Dr. Jeremy Jones explains why these discussions matter and highlights the growing incidence of colorectal cancer among younger adults. https://t.co/MHxEdGM770

[Dr. Yakubu Sani Wudil @yakubwudil]

We are planning to host a webinar this Saturday under the Arewa Youth Mentorship Program on Career Development Strategies and Preparing for Global Job Opportunities.

The session shall equip you with the knowledge, skills, and strategies needed to compete successfully in today's global job market, positioning yourself for international opportunities.

Stay tuned for the official announcement.